Obinutuzumab for Chronic Lymphocytic Leukemia User Reviews
Brand names: Gazyva
Reviews may be edited to correct grammar/spelling or to remove inappropriate language and content. Reviews that appear to be created by parties with a vested interest are not published. This information is not intended to endorse any particular medication. While these reviews may be helpful, they are not a substitute for the expertise, knowledge, and judgement of healthcare professionals.
Learn more about Chronic Lymphocytic Leukemia
Care guides
Symptoms and treatments
More about obinutuzumab
- Check interactions
- Compare alternatives
- Reviews (3)
- Side effects
- Dosage information
- During pregnancy
- Drug class: CD20 monoclonal antibodies
- Breastfeeding
- En español
Gazyva (obinutuzumab) "I was very happy with the results. I was up to 83,000 white count and after the first treatment it was down to 5,300. After one month it was still down. I go back in Sept. For my next blood test."